Literature DB >> 17420474

Combinatorial RNAi for quantitative protein network analysis.

Ozgür Sahin1, Christian Löbke, Ulrike Korf, Heribert Appelhans, Holger Sültmann, Annemarie Poustka, Stefan Wiemann, Dorit Arlt.   

Abstract

The elucidation of cross-talk events between intersecting signaling pathways is one main challenge in biological research. The complexity of protein networks, composed of different pathways, requires novel strategies and techniques to reveal relevant interrelations. Here, we established a combinatorial RNAi strategy for systematic single, double, and triple knockdown, and we measured the residual mRNAs and proteins quantitatively by quantitative real-time PCR and reverse-phase protein arrays, respectively, as a prerequisite for data analysis. Our results show that the parallel knockdown of at least three different genes is feasible while keeping both untargeted silencing and cytotoxicity low. The technique was validated by investigating the interplay of tyrosine kinase receptor ErbB2 and its downstream targets Akt-1 and MEK1 in cell invasion. This experimental approach combines multiple gene knockdown with a subsequent quantitative validation of reduced protein expression and is a major advancement toward the analysis of signaling pathways in systems biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420474      PMCID: PMC1849961          DOI: 10.1073/pnas.0606827104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  Insulin-like growth factors and neoplasia.

Authors:  Michael N Pollak; Eva S Schernhammer; Susan E Hankinson
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  Molecular basis for Rho GTPase signaling specificity.

Authors:  Antoine E Karnoub; Marc Symons; Sharon L Campbell; Channing J Der
Journal:  Breast Cancer Res Treat       Date:  2004-03       Impact factor: 4.872

Review 3.  The signaling network of tumor invasion.

Authors:  G K Wang; W Zhang
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

4.  Precision and variance components in quantitative gel electrophoresis.

Authors:  Angela Koller; Hermann Wätzig
Journal:  Electrophoresis       Date:  2005-06       Impact factor: 3.535

5.  Infrared-based protein detection arrays for quantitative proteomics.

Authors:  Christian Loebke; Holger Sueltmann; Christian Schmidt; Frauke Henjes; Stefan Wiemann; Annemarie Poustka; Ulrike Korf
Journal:  Proteomics       Date:  2007-02       Impact factor: 3.984

6.  Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.

Authors:  X Jing; K Kakudo; M Murakami; Y Nakamura; M Nakamura; T Yokoi; Q Yang; S Oura; T Sakurai
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

Review 7.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

8.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.

Authors:  Sarah E Seton-Rogers; Yu Lu; Lisa M Hines; Malvika Koundinya; Joshua LaBaer; Senthil K Muthuswamy; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

9.  Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.

Authors:  Peter C Scacheri; Orit Rozenblatt-Rosen; Natasha J Caplen; Tyra G Wolfsberg; Lowell Umayam; Jeffrey C Lee; Christina M Hughes; Kalai Selvi Shanmugam; Arindam Bhattacharjee; Matthew Meyerson; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

10.  Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference.

Authors:  Fangtian Huang; Anastasia Khvorova; William Marshall; Alexander Sorkin
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  26 in total

1.  Reno: regularized non-parametric analysis of protein lysate array data.

Authors:  Bin Li; Feng Liang; Jianhua Hu; And Xuming He
Journal:  Bioinformatics       Date:  2012-03-30       Impact factor: 6.937

Review 2.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

Review 3.  Integrating physical and genetic maps: from genomes to interaction networks.

Authors:  Andreas Beyer; Sourav Bandyopadhyay; Trey Ideker
Journal:  Nat Rev Genet       Date:  2007-09       Impact factor: 53.242

Review 4.  Towards genome-scale signalling network reconstructions.

Authors:  Daniel R Hyduke; Bernhard Ø Palsson
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

5.  Microarray-integrated optoelectrofluidic immunoassay system.

Authors:  Dongsik Han; Je-Kyun Park
Journal:  Biomicrofluidics       Date:  2016-05-12       Impact factor: 2.800

6.  Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Authors:  Özge Saatci; Simone Borgoni; Özge Akbulut; Selvi Durmuş; Umar Raza; Erol Eyüpoğlu; Can Alkan; Aytekin Akyol; Özgür Kütük; Stefan Wiemann; Özgür Şahin
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

7.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

8.  Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance.

Authors:  Ozgür Sahin; Holger Fröhlich; Christian Löbke; Ulrike Korf; Sara Burmester; Meher Majety; Jens Mattern; Ingo Schupp; Claudine Chaouiya; Denis Thieffry; Annemarie Poustka; Stefan Wiemann; Tim Beissbarth; Dorit Arlt
Journal:  BMC Syst Biol       Date:  2009-01-01

9.  Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.

Authors:  Jan C Brase; Heiko Mannsperger; Holger Fröhlich; Stephan Gade; Christian Schmidt; Stefan Wiemann; Tim Beissbarth; Thorsten Schlomm; Holger Sültmann; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-06-22       Impact factor: 2.480

10.  Deterministic Effects Propagation Networks for reconstructing protein signaling networks from multiple interventions.

Authors:  Holger Fröhlich; Ozgür Sahin; Dorit Arlt; Christian Bender; Tim Beissbarth
Journal:  BMC Bioinformatics       Date:  2009-10-08       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.